Drug Discovery and Drug Development 2021
DOI: 10.1007/978-981-15-8002-4_5
|View full text |Cite
|
Sign up to set email alerts
|

Modern Drug Discovery and Development in the Area of Leishmaniasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 148 publications
0
1
0
Order By: Relevance
“…Among the four pyrazolopyrimidine isomers (see Scheme 1), pyrazolo [1,5-c]pyrimidines are the least studied in terms of synthesis, structure or biological activities (Elnagdi et al, 1987). Chemotypes based on pyrazolo [1,5-c]pyrimidines have been shown to possess antileishmanial activity (Atta et al, 2017;Goyal et al, 2021) and antiviral activity against herpesviruses (Gudmundsson et al, 2009). Pyrazolotriazolo-[1,5-c]pyrimidine derivatives have been reported as adenosine receptor antagonists (Federico et al, 2012;Baraldi et al, 2012;Redenti et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Among the four pyrazolopyrimidine isomers (see Scheme 1), pyrazolo [1,5-c]pyrimidines are the least studied in terms of synthesis, structure or biological activities (Elnagdi et al, 1987). Chemotypes based on pyrazolo [1,5-c]pyrimidines have been shown to possess antileishmanial activity (Atta et al, 2017;Goyal et al, 2021) and antiviral activity against herpesviruses (Gudmundsson et al, 2009). Pyrazolotriazolo-[1,5-c]pyrimidine derivatives have been reported as adenosine receptor antagonists (Federico et al, 2012;Baraldi et al, 2012;Redenti et al, 2016).…”
Section: Introductionmentioning
confidence: 99%